Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Artificial Human Skin Created Using Tissue Engineering

By HospiMedica International staff writers
Posted on 03 May 2010
A new study describes the development of artificial human skin with biomechanical properties, based on an agarose-fibrin biomaterial.

Researchers at the University of Granada (UGR; Spain) first obtained human skin samples from biopsies of patients who underwent plastic surgery at the University Hospital Virgen de las Nieves (Granada, Spain). More...
To create the artificial human skin, tranexamic acid (to prevent fibrinolysis), calcium chloride (to precipitate fibrin coagulation), and 0.1% agarose was added to human fibrin from plasma of healthy donors. The artificial-skin substitutes were then grafted on the back of the nude mice, with the purpose of observing its optimal development, maturation, and functionality in vivo. To do so, the researchers analyzed the samples by transmission and scanning light, electron microscopy, and inmunofluorescence to evaluate factors such as cell proliferation, the presence of differentiating morphological markers, the expression of cytokeratin, involucrine, filaggrin, and angiogenesis of the artificial skin into the recipient organism.

The researchers found that the artificial human skin created in the laboratory showed adequate biocompatibility rates with the recipient, and no rejection, dehiscence, or infection was registered. Additionally, the skin of all animals used in the study started to show granulation after six days from implantation. Within the following twenty days, cicatrization was complete. Details on the research were released by the department of histology at UGR on April 20, 2010.

"These biomaterials added resistance, firmness, and elasticity to the skin. Definitively, we have created a more stable skin with similar functionality to normal human skin,” said lead author José María Jiménez Rodríguez, of the tissular engineering research group at UGR. ”This pioneering finding will allow the clinical use of human skin and its use in many laboratory tests on biological tissues. Further, this finding could be useful in developing new treatment approaches for dermatological pathologies.”

Related Links:
University of Granada
University Hospital Virgen de las Nieves


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.